Description and Rationale:
Ischemia reperfusion injury (IRI) limits transplant survival and availability of organs. In this webinar, participants will learn about changes induced by IRI on the level of gene expression for a more basic understanding of the matter. In the second talk, participants will learn about possibilities of ex vivo perfusion and its impact on allograft survival and clinical outcome. Focus is the translational aspect of this topic from the epigenetic mechanisms underlying IRI to ex vivo liver perfusion. After this webinar, participants should be able to understand the regulation of ischemia reperfusion injury at the level of epigenetics and also know about the latest findings in ex vivo liver perfusion for the prevention of IRI.
· Ischemia reperfusion injury
· ex vivo perfusion
All fields involved in health care and research with affiliation in transplantation. I.e. Transplant Scientists, Transplant Surgeons and Clinicians, Researchers in transplant related fields (Immunology, Stem cells, Regenerative Medicine). Physicians, Nurses, Coordinators, Pharmacists with Involvement or interest in the field of transplantation, Students working in or interested in the field of transplantation immunology, Patients interested in the newest research